Clinical Trials Logo

Healthy Subject clinical trials

View clinical trials related to Healthy Subject.

Filter by:

NCT ID: NCT03698318 Completed - Healthy Subject Clinical Trials

Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts

KING
Start date: October 15, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to assess bioavailability of total gingeroids, free gingerols and shogaols, so as their glucuronide and sulfate metabolites, in the plasma, after consumption of a single dose of 5 different ginger extracts. These five extracts have the same quantity of active substance but with different titration (1.6%, 5%, 39%, 26% and 26% NOP80).

NCT ID: NCT03680235 Completed - Healthy Subject Clinical Trials

Informational Intervention in Increasing Lactation Practices by African American Women

Start date: July 11, 2016
Phase: N/A
Study type: Interventional

This trial studies how well an informational intervention works in increasing lactation practices by African American women. Giving additional information about breastfeeding and breast cancer risks to African American women may help doctors understand the factors that affect the decision to breast feed and to test whether providing useful information about breastfeeding will change breastfeeding behavior.

NCT ID: NCT03662399 Completed - Healthy Subject Clinical Trials

Francis Biomechanics Study

Start date: June 13, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of a range of pre-formed orthoses on function of the foot and leg to generate technical data on how the individual insoles impact gait, distribution of load and stability in a healthy population.

NCT ID: NCT03650608 Completed - Healthy Subject Clinical Trials

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects

Start date: August 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and PK parameters in healthy subjects.

NCT ID: NCT03588156 Completed - Healthy Subject Clinical Trials

Single-dose PK Study of Benapenem In Healthy Subjects

Start date: March 11, 2015
Phase: Phase 1
Study type: Interventional

To design 11 dose groups within 62.5 mg ~ 4000 mg for single-dose tolerability study. A single-center, randomized, blinded, placebo-controlled, dose escalation trial design is adopted. 8 subjects each in 62.5 mg, 125 mg, 3000 mg and 4000 mg dose groups, 10 subjects each in other groups, including 2 placebo-controlled subjects. To be carried out from low-dose group to high-dose group. The next dose group can be studied only when the observation of the previous dose group is completed and it is confirmed that the drug is safely tolerated. The test should be stopped in case of serious adverse reactions, or when more subjects experience adverse reactions and have reached termination criteria of the trial, even if the maximum dose has not been reached. Infusion time is planned to be 30 min in 62.5 mg, 125 mg and 250 mg ; two infusion time, 30 min and 60 min, in 500 mg, 1000 mg and 2000 mg groups. If subjects can tolerate 60-min infusion, the same dose group at infusion time of 30 min is added. The 3000 mg and 4000 mg dose groups only receive 60-min infusion for investigation of tolerability.

NCT ID: NCT03584100 Completed - Healthy Subject Clinical Trials

Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal

Start date: November 7, 2018
Phase: N/A
Study type: Interventional

The purpose of the proposed study is to evaluate the acute impact of swelling caused by low-pressure tourniquet use in the setting of ipsilateral prior axillary lymph node dissection and the change in swelling reduction following tourniquet use in three limb postures versus healthy volunteers.

NCT ID: NCT03570970 Completed - Healthy Subject Clinical Trials

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects

Start date: March 14, 2016
Phase: Phase 1
Study type: Interventional

To observe the pharmacokinetic profiles of benapenem and its major metabolites in healthy volunteers after continuous multiple-dose benapenem, providing evidence for phase Ⅱ clinical study.

NCT ID: NCT03539731 Completed - Glioblastoma Clinical Trials

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Start date: April 23, 2018
Phase: Phase 1
Study type: Interventional

This phase I trial studies how well [18F]DASA-23 and positron emission tomography (PET) scan work in evaluating pyruvate kinase M2 (PKM2) expression in patients with intracranial tumors or recurrent glioblastoma and healthy volunteers. PKM2 regulates brain tumor metabolism, a key factor in glioblastoma growth. [18F]DASA-23 is a radioactive substance with the ability to monitor PKM2 activity. A PET scan is a procedure in which a small amount of a radioactive substance, such as [18F]DASA-23, is injected into a vein, and a scanner is used to make detailed, computerized pictures of areas inside the body where the substance is used. Tumor cells usually pick up more of these radioactive substances, allowing them to be found. Giving [18F]DASA-23 with a PET scan may help doctors evaluate PKM2 expression in healthy volunteers and in participants with intracranial tumors or recurrent glioblastoma.

NCT ID: NCT03457480 Completed - Healthy Subject Clinical Trials

Text Messages in Preventing Tobacco Use in Young Adults

Start date: September 20, 2013
Phase: N/A
Study type: Interventional

This trial studies how well text messages work in preventing tobacco use in young adults. Text messaging may help to teach young adults about the risks of tobacco products.

NCT ID: NCT03448224 Completed - Healthy Subject Clinical Trials

Behavioral Intervention in Reducing Indoor Tanning

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

This randomized clinical trial tests the efficacy of a behavioral intervention works in reducing indoor tanning. Artificial ultraviolet indoor tanning increases the chance of developing skin cancers. Behavioral interventions use techniques to help participants change the way they react to environmental triggers that may cause a negative reaction.